Stay updated on Frailty-guided Dosing in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.

Latest updates to the Frailty-guided Dosing in Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check17 days agoChange DetectedA banner announces NIH website changes and says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.7%

- Check24 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2, while the study record appears unchanged.SummaryDifference0.1%

- Check31 days agoChange DetectedThe website footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now shows an added revision entry for v3.7.0 and the removal of v3.6.6, indicating the page’s version history was updated to reflect the latest documentation of changes.SummaryDifference0.1%

- Check73 days agoChange DetectedThe version history now includes a new entry Revision: v3.6.6 and the previous Revision: v3.6.5 entry is removed.SummaryDifference0.1%

Stay in the know with updates to Frailty-guided Dosing in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frailty-guided Dosing in Myeloma Clinical Trial page.